Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.150
+0.040 (3.60%)
At close: Dec 12, 2025, 4:00 PM EST
1.160
+0.010 (0.87%)
Pre-market: Dec 15, 2025, 8:40 AM EST
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $132.66 million as of December 15, 2025. Its market cap has decreased by -56.54% in one year.
Market Cap
132.66M
Enterprise Value
-3.52M
1-Year Change
-56.54%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $132.66M, an increase of 5.20%. That is a compound annual growth rate of 0.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 132.70M | -29.38% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
| Oct 1, 2013 | 126.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |